 | • レポートコード：MRC2012B1483 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Service & Software |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ウィメンズヘルスの世界市場を広く調査・分析し、今後の市場展望をまとめております。ウィメンズヘルスの種類別市場規模（ホルモン療法、非ホルモン療法）、用途別市場規模（閉経後骨粗鬆症、不妊症、子宮内膜症、避妊薬、閉経、多嚢胞性卵巣症候群（PCOS））、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Agile Therapeutics、Merck、AstraZeneca、Allergan、Ferring、Amgen、Teva、Bristol-Myers Squibb Company、Bayer AG、Pfizer、 ・地域別グローバル市場分析 2015年-2020年 ・ウィメンズヘルスの北米市場（アメリカ、カナダ、メキシコ） ・ウィメンズヘルスのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ウィメンズヘルスのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ウィメンズヘルスの南米市場（ブラジル、アルゼンチン） ・ウィメンズヘルスの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ホルモン療法、非ホルモン療法 ・用途別分析：閉経後骨粗鬆症、不妊症、子宮内膜症、避妊薬、閉経、多嚢胞性卵巣症候群（PCOS） ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Women’s Health market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Women’s Health market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Women’s Health market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Women’s Health market has been segmented into:
Hormonal Treatment
Non-Hormonal Treatment
By Application, Women’s Health has been segmented into:
Postmenopausal Osteoporosis
Infertility
Endometriosis
Contraceptives
Menopause
Polycystic Ovary Syndrome (PCOS)
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Women’s Health market presented in the report. This section sheds light on the sales growth of different regional and country-level Women’s Health markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Women’s Health market.
The report offers in-depth assessment of the growth and other aspects of the Women’s Health market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Women’s Health Market Share Analysis
Women’s Health competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Women’s Health sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Women’s Health sales, revenue and market share for each player covered in this report.
The major players covered in Women’s Health are:
Agile Therapeutics
Merck
AstraZeneca
Allergan
Ferring
Amgen
Teva
Bristol-Myers Squibb Company
Bayer AG
Pfizer
Table of Contents
1 Women’s Health Market Overview
1.1 Product Overview and Scope of Women’s Health
1.2 Classification of Women’s Health by Type
1.2.1 Global Women’s Health Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Women’s Health Revenue Market Share by Type in 2019
1.2.3 Hormonal Treatment
1.2.4 Non-Hormonal Treatment
1.3 Global Women’s Health Market by Application
1.3.1 Overview: Global Women’s Health Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Postmenopausal Osteoporosis
1.3.3 Infertility
1.3.4 Endometriosis
1.3.5 Contraceptives
1.3.6 Menopause
1.3.7 Polycystic Ovary Syndrome (PCOS)
1.4 Global Women’s Health Market by Regions
1.4.1 Global Women’s Health Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Women’s Health (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Women’s Health Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Women’s Health Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Women’s Health Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Women’s Health Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Women’s Health Status and Prospect (2015-2025)
2 Company Profiles
2.1 Agile Therapeutics
2.1.1 Agile Therapeutics Details
2.1.2 Agile Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Agile Therapeutics SWOT Analysis
2.1.4 Agile Therapeutics Product and Services
2.1.5 Agile Therapeutics Women’s Health Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merck SWOT Analysis
2.2.4 Merck Product and Services
2.2.5 Merck Women’s Health Revenue, Gross Margin and Market Share (2018-2019)
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 AstraZeneca SWOT Analysis
2.3.4 AstraZeneca Product and Services
2.3.5 AstraZeneca Women’s Health Revenue, Gross Margin and Market Share (2018-2019)
2.4 Allergan
2.4.1 Allergan Details
2.4.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Allergan SWOT Analysis
2.4.4 Allergan Product and Services
2.4.5 Allergan Women’s Health Revenue, Gross Margin and Market Share (2018-2019)
2.5 Ferring
2.5.1 Ferring Details
2.5.2 Ferring Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Ferring SWOT Analysis
2.5.4 Ferring Product and Services
2.5.5 Ferring Women’s Health Revenue, Gross Margin and Market Share (2018-2019)
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Amgen SWOT Analysis
2.6.4 Amgen Product and Services
2.6.5 Amgen Women’s Health Revenue, Gross Margin and Market Share (2018-2019)
2.7 Teva
2.7.1 Teva Details
2.7.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Teva SWOT Analysis
2.7.4 Teva Product and Services
2.7.5 Teva Women’s Health Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bristol-Myers Squibb Company
2.8.1 Bristol-Myers Squibb Company Details
2.8.2 Bristol-Myers Squibb Company Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bristol-Myers Squibb Company SWOT Analysis
2.8.4 Bristol-Myers Squibb Company Product and Services
2.8.5 Bristol-Myers Squibb Company Women’s Health Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bayer AG
2.9.1 Bayer AG Details
2.9.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bayer AG SWOT Analysis
2.9.4 Bayer AG Product and Services
2.9.5 Bayer AG Women’s Health Revenue, Gross Margin and Market Share (2018-2019)
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Pfizer SWOT Analysis
2.10.4 Pfizer Product and Services
2.10.5 Pfizer Women’s Health Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Women’s Health Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Women’s Health Players Market Share
3.2.2 Top 10 Women’s Health Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Women’s Health Revenue and Market Share by Regions
4.2 North America Women’s Health Revenue and Growth Rate (2015-2020)
4.3 Europe Women’s Health Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Women’s Health Revenue and Growth Rate (2015-2020)
4.5 South America Women’s Health Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Women’s Health Revenue and Growth Rate (2015-2020)
5 North America Women’s Health Revenue by Countries
5.1 North America Women’s Health Revenue by Countries (2015-2020)
5.2 USA Women’s Health Revenue and Growth Rate (2015-2020)
5.3 Canada Women’s Health Revenue and Growth Rate (2015-2020)
5.4 Mexico Women’s Health Revenue and Growth Rate (2015-2020)
6 Europe Women’s Health Revenue by Countries
6.1 Europe Women’s Health Revenue by Countries (2015-2020)
6.2 Germany Women’s Health Revenue and Growth Rate (2015-2020)
6.3 UK Women’s Health Revenue and Growth Rate (2015-2020)
6.4 France Women’s Health Revenue and Growth Rate (2015-2020)
6.5 Russia Women’s Health Revenue and Growth Rate (2015-2020)
6.6 Italy Women’s Health Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Women’s Health Revenue by Countries
7.1 Asia-Pacific Women’s Health Revenue by Countries (2015-2020)
7.2 China Women’s Health Revenue and Growth Rate (2015-2020)
7.3 Japan Women’s Health Revenue and Growth Rate (2015-2020)
7.4 Korea Women’s Health Revenue and Growth Rate (2015-2020)
7.5 India Women’s Health Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Women’s Health Revenue and Growth Rate (2015-2020)
8 South America Women’s Health Revenue by Countries
8.1 South America Women’s Health Revenue by Countries (2015-2020)
8.2 Brazil Women’s Health Revenue and Growth Rate (2015-2020)
8.3 Argentina Women’s Health Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Women’s Health by Countries
9.1 Middle East & Africa Women’s Health Revenue by Countries (2015-2020)
9.2 Saudi Arabia Women’s Health Revenue and Growth Rate (2015-2020)
9.3 UAE Women’s Health Revenue and Growth Rate (2015-2020)
9.4 Egypt Women’s Health Revenue and Growth Rate (2015-2020)
9.5 South Africa Women’s Health Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Women’s Health Revenue and Market Share by Type (2015-2020)
10.2 Global Women’s Health Market Forecast by Type (2019-2024)
10.3 Hormonal Treatment Revenue Growth Rate (2015-2025)
10.4 Non-Hormonal Treatment Revenue Growth Rate (2015-2025)
11 Global Women’s Health Market Segment by Application
11.1 Global Women’s Health Revenue Market Share by Application (2015-2020)
11.2 Women’s Health Market Forecast by Application (2019-2024)
11.3 Postmenopausal Osteoporosis Revenue Growth (2015-2020)
11.4 Infertility Revenue Growth (2015-2020)
11.5 Endometriosis Revenue Growth (2015-2020)
11.6 Contraceptives Revenue Growth (2015-2020)
11.7 Menopause Revenue Growth (2015-2020)
11.8 Polycystic Ovary Syndrome (PCOS) Revenue Growth (2015-2020)
12 Global Women’s Health Market Size Forecast (2021-2025)
12.1 Global Women’s Health Market Size Forecast (2021-2025)
12.2 Global Women’s Health Market Forecast by Regions (2021-2025)
12.3 North America Women’s Health Revenue Market Forecast (2021-2025)
12.4 Europe Women’s Health Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Women’s Health Revenue Market Forecast (2021-2025)
12.6 South America Women’s Health Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Women’s Health Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Women's Health Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Women's Health by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Women's Health Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Women's Health Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Agile Therapeutics Corporate Information, Location and Competitors
Table 6. Agile Therapeutics Women's Health Major Business
Table 7. Agile Therapeutics Women's Health Total Revenue (USD Million) (2017-2018)
Table 8. Agile Therapeutics SWOT Analysis
Table 9. Agile Therapeutics Women's Health Product and Solutions
Table 10. Agile Therapeutics Women's Health Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Merck Corporate Information, Location and Competitors
Table 12. Merck Women's Health Major Business
Table 13. Merck Women's Health Total Revenue (USD Million) (2018-2019)
Table 14. Merck SWOT Analysis
Table 15. Merck Women's Health Product and Solutions
Table 16. Merck Women's Health Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. AstraZeneca Corporate Information, Location and Competitors
Table 18. AstraZeneca Women's Health Major Business
Table 19. AstraZeneca Women's Health Total Revenue (USD Million) (2017-2018)
Table 20. AstraZeneca SWOT Analysis
Table 21. AstraZeneca Women's Health Product and Solutions
Table 22. AstraZeneca Women's Health Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Allergan Corporate Information, Location and Competitors
Table 24. Allergan Women's Health Major Business
Table 25. Allergan Women's Health Total Revenue (USD Million) (2017-2018)
Table 26. Allergan SWOT Analysis
Table 27. Allergan Women's Health Product and Solutions
Table 28. Allergan Women's Health Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Ferring Corporate Information, Location and Competitors
Table 30. Ferring Women's Health Major Business
Table 31. Ferring Women's Health Total Revenue (USD Million) (2017-2018)
Table 32. Ferring SWOT Analysis
Table 33. Ferring Women's Health Product and Solutions
Table 34. Ferring Women's Health Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Amgen Corporate Information, Location and Competitors
Table 36. Amgen Women's Health Major Business
Table 37. Amgen Women's Health Total Revenue (USD Million) (2017-2018)
Table 38. Amgen SWOT Analysis
Table 39. Amgen Women's Health Product and Solutions
Table 40. Amgen Women's Health Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Teva Corporate Information, Location and Competitors
Table 42. Teva Women's Health Major Business
Table 43. Teva Women's Health Total Revenue (USD Million) (2017-2018)
Table 44. Teva SWOT Analysis
Table 45. Teva Women's Health Product and Solutions
Table 46. Teva Women's Health Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Bristol-Myers Squibb Company Corporate Information, Location and Competitors
Table 48. Bristol-Myers Squibb Company Women's Health Major Business
Table 49. Bristol-Myers Squibb Company Women's Health Total Revenue (USD Million) (2017-2018)
Table 50. Bristol-Myers Squibb Company SWOT Analysis
Table 51. Bristol-Myers Squibb Company Women's Health Product and Solutions
Table 52. Bristol-Myers Squibb Company Women's Health Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Bayer AG Corporate Information, Location and Competitors
Table 54. Bayer AG Women's Health Major Business
Table 55. Bayer AG Women's Health Total Revenue (USD Million) (2017-2018)
Table 56. Bayer AG SWOT Analysis
Table 57. Bayer AG Women's Health Product and Solutions
Table 58. Bayer AG Women's Health Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Pfizer Corporate Information, Location and Competitors
Table 60. Pfizer Women's Health Major Business
Table 61. Pfizer Women's Health Total Revenue (USD Million) (2017-2018)
Table 62. Pfizer SWOT Analysis
Table 63. Pfizer Women's Health Product and Solutions
Table 64. Pfizer Women's Health Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Women's Health Revenue (Million USD) by Players (2015-2020)
Table 66. Global Women's Health Revenue Share by Players (2015-2020)
Table 67. Global Women's Health Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Women's Health Revenue Market Share by Regions (2015-2020)
Table 69. North America Women's Health Revenue by Countries (2015-2020)
Table 70. North America Women's Health Revenue Market Share by Countries (2015-2020)
Table 71. Europe Women's Health Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Women's Health Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Women's Health Revenue by Countries (2015-2020)
Table 74. South America Women's Health Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Women's Health Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Women's Health Revenue Market Share by Countries (2015-2020)
Table 77. Global Women's Health Revenue (Million USD) by Type (2015-2020)
Table 78. Global Women's Health Revenue Share by Type (2015-2020)
Table 79. Global Women's Health Revenue Forecast by Type (2021-2025)
Table 80. Global Women's Health Revenue by Application (2015-2020)
Table 81. Global Women's Health Revenue Share by Application (2015-2020)
Table 82. Global Women's Health Revenue Forecast by Application (2021-2025)
Table 83. Global Women's Health Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Women's Health Picture
Figure 2. Global Women's Health Revenue Market Share by Type in 2019
Figure 3. Hormonal Treatment Picture
Figure 4. Non-Hormonal Treatment Picture
Figure 5. Women's Health Revenue Market Share by Application in 2019
Figure 6. Postmenopausal Osteoporosis Picture
Figure 7. Infertility Picture
Figure 8. Endometriosis Picture
Figure 9. Contraceptives Picture
Figure 10. Menopause Picture
Figure 11. Polycystic Ovary Syndrome (PCOS) Picture
Figure 12. Global Women's Health Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Women's Health Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Women's Health Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Women's Health Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Women's Health Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Women's Health Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Women's Health Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Women's Health Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Women's Health Revenue Market Share in 2019
Figure 21. Global Top 10 Players Women's Health Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Women's Health Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Women's Health Revenue Market Share by Regions (2015-2020)
Figure 25. Global Women's Health Revenue Market Share by Regions in 2018
Figure 26. North America Women's Health Revenue and Growth Rate (2015-2020)
Figure 27. Europe Women's Health Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Women's Health Revenue and Growth Rate (2015-2020)
Figure 29. South America Women's Health Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Women's Health Revenue and Growth Rate (2015-2020)
Figure 31. North America Women's Health Revenue Market Share by Countries (2015-2020)
Figure 32. North America Women's Health Revenue Market Share by Countries in 2019
Figure 33. USA Women's Health Revenue and Growth Rate (2015-2020)
Figure 34. Canada Women's Health Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Women's Health Revenue and Growth Rate (2015-2020)
Figure 36. Europe Women's Health Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Women's Health Revenue Market Share by Countries in 2019
Figure 38. Germany Women's Health Revenue and Growth Rate (2015-2020)
Figure 39. UK Women's Health Revenue and Growth Rate (2015-2020)
Figure 40. France Women's Health Revenue and Growth Rate (2015-2020)
Figure 41. Russia Women's Health Revenue and Growth Rate (2015-2020)
Figure 42. Italy Women's Health Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Women's Health Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Women's Health Revenue Market Share by Countries in 2019
Figure 45. China Women's Health Revenue and Growth Rate (2015-2020)
Figure 46. Japan Women's Health Revenue and Growth Rate (2015-2020)
Figure 47. Korea Women's Health Revenue and Growth Rate (2015-2020)
Figure 48. India Women's Health Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Women's Health Revenue and Growth Rate (2015-2020)
Figure 50. South America Women's Health Revenue Market Share by Countries (2015-2020)
Figure 51. South America Women's Health Revenue Market Share by Countries in 2019
Figure 52. Brazil Women's Health Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Women's Health Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Women's Health Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Women's Health Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Women's Health Revenue and Growth Rate (2015-2020)
Figure 57. UAE Women's Health Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Women's Health Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Women's Health Revenue and Growth Rate (2015-2020)
Figure 60. Global Women's Health Revenue Share by Type (2015-2020)
Figure 61. Global Women's Health Revenue Share by Type in 2019
Figure 62. Global Women's Health Market Share Forecast by Type (2021-2025)
Figure 63. Global Hormonal Treatment Revenue Growth Rate (2015-2020)
Figure 64. Global Non-Hormonal Treatment Revenue Growth Rate (2015-2020)
Figure 65. Global Women's Health Revenue Share by Application (2015-2020)
Figure 66. Global Women's Health Revenue Share by Application in 2019
Figure 67. Global Women's Health Market Share Forecast by Application (2021-2025)
Figure 68. Global Postmenopausal Osteoporosis Revenue Growth Rate (2015-2020)
Figure 69. Global Infertility Revenue Growth Rate (2015-2020)
Figure 70. Global Endometriosis Revenue Growth Rate (2015-2020)
Figure 71. Global Contraceptives Revenue Growth Rate (2015-2020)
Figure 72. Global Menopause Revenue Growth Rate (2015-2020)
Figure 73. Global Polycystic Ovary Syndrome (PCOS) Revenue Growth Rate (2015-2020)
Figure 74. Global Women's Health Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Women's Health Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Women's Health Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Women's Health Revenue Market Forecast (2021-2025)
Figure 78. Europe Women's Health Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Women's Health Revenue Market Forecast (2021-2025)
Figure 80. South America Women's Health Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Women's Health Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
女性健康治療の世界市場（～2026年） Women's experience of health and disease differ from those of men, due to unique biological, social and behavioural conditions. Biological differences vary all the way from phenotype to the cellular, and manifest unique risks for the development of ill health. Rise in cases of infertility and increa…- 女性健康診断の世界市場（～2026年） Women's experience of health and disease differ from those of men, due to unique biological, social and behavioural conditions. Biological differences vary all the way from phenotype to the cellular, and manifest unique risks for the development of ill health. Rising prevalence of infectious disease…
- 女性健康リハビリテーション製品の世界市場（～2026年） Women rehabilitation products and services (therapy) are used to aid in the recovery of women who have undergone pregnancy (prenatal and post-natal), met with an accident, undergone surgery, or suffering from chronic diseases such as urinary tract infection (UTI), osteoporosis, and lymphedema. Women…
- 男性型・女性型脱毛症の世界市場（～2026年） Market Analysis and Insights: Global Hair Loss Men and Women Market The global Hair Loss Men and Women market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Hair Loss Men and Women Scope and Market Size Hair Loss Men and Wom…
- 女性用パターの世界市場（～2026年） A putter is a club used in the sport of golf to make relatively short and low-speed strokes with the intention of rolling the ball into the hole from a short distance away. Market Analysis and Insights: Global Women's Putters Market The global Women's Putters market size is projected to reach US$ XX…